Cardiac Clinic
Lorem ipsum dolor sit amet, cons ectetuer. Proin gravida nibh vel velit auctor aliquet aenean
Primary Care
Lorem ipsum dolor sit amet, cons ectetuer. Proin gravida nibh vel velit auctor aliquet aenean
Emergency Clinic
Lorem ipsum dolor sit amet, cons ectetuer. Proin gravida nibh vel velit auctor aliquet aenean
Vascular Surgery
Lorem ipsum dolor sit amet, cons ectetuer. Proin gravida nibh vel velit auctor aliquet aenean
Precise Diagnosis
Lorem ipsum dolor sit amet, cons ectetuer. Proin gravida nibh vel velit auctor aliquet aenean
General Surgery
Lorem ipsum dolor sit amet, cons ectetuer. Proin gravida nibh vel velit auctor aliquet aenean
Health Sections
Different Services
Blood Donations
Satisfied Patients
Chosen For Excellence
Ut wisi enim ad minim veniam, quis laore est usus legentis in iis qui facit eorum nostrud exerci tation ulm hedi corper turet suscipit lobortis nisl
Care For Your Smile
Ut wisi enim ad minim veniam, quis laore est usus legentis in iis qui facit eorum nostrud exerci tation ulm hedi corper turet suscipit lobortis nisl
Dentistry With Heart
Ut wisi enim ad minim veniam, quis laore est usus legentis in iis qui facit eorum nostrud exerci tation ulm hedi corper turet suscipit lobortis nisl
Robert W. Sims, MBA
Chief Executive Officer
Military veteran with 20 years of progressive industry experience involving design, development, and launch of device, diagnostic and therapeutic products across multiple specialties.
Manya Deehr, JD
Chief Legal Officer
25 years of collaborative experience facilitating debt Financing and IPO activity for drug discover, development and commercialization deals in excess of $25B.
Tre Thompson
Chief Operations Officer
18 years of experience as a pharmaceutical executive serving in sales and marketing roles to include product development, team building, commercialization, managed-care contracting and trade negotiations.
Shanta Bantia, PhD
Chief Science Officer
20+ years in R&D, grant procurement, and clinical trial operations; Dr. Bantia has raised an excess of $200M via grants, holds multiple U.S. patents, and has advanced several compounds to market.